title: Dopamine agonist-induced impulse control disorders in a patient with prolactinoma.
authors.affiliation: Department of Psychiatry, Mount Sinai School of Medicine at Elmhurst Hospital Center, Elmhurst, NY 11373, USA. ALMANZAS@nychhc.org
authors.forename: Santiago
authors.initials: S
authors.lastname: Almanzar
authors.forename: Maria I
authors.initials: MI
authors.lastname: Zapata-Vega
authors.forename: Juan A
authors.initials: JA
authors.lastname: Raya
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects*; D000077465:Cabergoline; D003220:Conflict, Psychological; D003863:Depression / Q000188:drug therapy; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000139:chemically induced*; D018491:Dopamine Agonists / Q000009:adverse effects*; D004873:Ergolines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D020280:Sertraline / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D001971:Bromocriptine; D000077465:Cabergoline; D018491:Dopamine Agonists; D004873:Ergolines; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline